Correlation Between Predictive Oncology and Artelo Biosciences

Can any of the company-specific risk be diversified away by investing in both Predictive Oncology and Artelo Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Predictive Oncology and Artelo Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Predictive Oncology and Artelo Biosciences, you can compare the effects of market volatilities on Predictive Oncology and Artelo Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Predictive Oncology with a short position of Artelo Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Predictive Oncology and Artelo Biosciences.

Diversification Opportunities for Predictive Oncology and Artelo Biosciences

-0.62

Correlation Coefficient

Predictive Oncology  Artelo Biosciences

Excellent diversification

The 3 months correlation between Predictive and Artelo is -0.62. Overlapping area represents the amount of risk that can be diversified away by holding Predictive Oncology and Artelo Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Artelo Biosciences and Predictive Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Predictive Oncology are associated (or correlated) with Artelo Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Artelo Biosciences has no effect on the direction of Predictive Oncology i.e., Predictive Oncology and Artelo Biosciences go up and down completely randomly.

Pair Corralation between Predictive Oncology and Artelo Biosciences

Given the investment horizon of 90 days Predictive Oncology is expected to under-perform the Artelo Biosciences. But the stock apears to be less risky and, when comparing its historical volatility, Predictive Oncology is 4.02 times less risky than Artelo Biosciences. The stock trades about -0.04 of its potential returns per unit of risk. The Artelo Biosciences is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  543.00  in Artelo Biosciences on May 19, 2025 and sell it today you would earn a total of  459.00  from holding Artelo Biosciences or generate 84.53% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Predictive Oncology  vs.  Artelo Biosciences

Predictive Oncology

Risk-Adjusted Performance

Weakest

Over the last 90 days Predictive Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest conflicting performance, the Stock's basic indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the firm traders.

Artelo Biosciences

Risk-Adjusted Performance

Fair

Compared to the overall equity markets, risk-adjusted returns on investments in Artelo Biosciences are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite quite weak basic indicators, Artelo Biosciences disclosed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Predictive Oncology and Artelo Biosciences

The main advantage of trading using opposite Predictive Oncology and Artelo Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Predictive Oncology position performs unexpectedly, Artelo Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Artelo Biosciences will offset losses from the drop in Artelo Biosciences' long position.

The idea behind Predictive Oncology and Artelo Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.